PMID- 11698470 OWN - NLM STAT- MEDLINE DCOM- 20011207 LR - 20190515 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 167 IP - 10 DP - 2001 Nov 15 TI - Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. PG - 5928-34 AB - Malaria, caused by infection with Plasmodium spp., is a life cycle-specific disease that includes liver injury at the erythrocyte stage of the parasite. In this study, we have investigated the mechanisms underlying Plasmodium berghei-induced liver injury, which is characterized by the presence of apoptotic and necrotic hepatocytes and dense infiltration of lymphocytes. Although both IL-12 and IL-18 serum levels were elevated after infection, IL-12-deficient, but not IL-18-deficient, mice were resistant to liver injury induced by P. berghei. Neither elevation of serum IL-12 levels nor liver injury was observed in mice deficient in myeloid differentiation factor 88 (MyD88), an adaptor molecule shared by Toll-like receptors (TLRs). These results demonstrated a requirement of the TLR-MyD88 pathway for induction of IL-12 production during P. berghei infection. Hepatic lymphocytes from P. berghei-infected wild-type mice lysed hepatocytes from both uninfected and infected mice. The hepatocytotoxic action of these cells was blocked by a perforin inhibitor but not by a neutralizing anti-Fas ligand Ab and was up-regulated by IL-12. Surprisingly, these cells killed hepatocytes in an MHC-unrestricted manner. However, CD1d-deficient mice that lack CD1d-restricted NK T cells, were susceptible to liver injury induced by P. berghei. Collectively, our results indicate that the liver injury induced by P. berghei infection of mice induces activation of the TLR-MyD88 signaling pathway which results in IL-12 production and activation of the perforin-dependent cytotoxic activities of MHC-unrestricted hepatic lymphocytes. FAU - Adachi, K AU - Adachi K AD - Department of Immunology and Medical Zoology, Institute for Advanced Medical Science, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. FAU - Tsutsui, H AU - Tsutsui H FAU - Kashiwamura, S AU - Kashiwamura S FAU - Seki, E AU - Seki E FAU - Nakano, H AU - Nakano H FAU - Takeuchi, O AU - Takeuchi O FAU - Takeda, K AU - Takeda K FAU - Okumura, K AU - Okumura K FAU - Van Kaer, L AU - Van Kaer L FAU - Okamura, H AU - Okamura H FAU - Akira, S AU - Akira S FAU - Nakanishi, K AU - Nakanishi K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Antigens, CD1) RN - 0 (Antigens, CD1d) RN - 0 (Antigens, Differentiation) RN - 0 (Drosophila Proteins) RN - 0 (Fas Ligand Protein) RN - 0 (Fasl protein, mouse) RN - 0 (Interleukin-18) RN - 0 (Membrane Glycoproteins) RN - 0 (Myd88 protein, mouse) RN - 0 (Myeloid Differentiation Factor 88) RN - 0 (Pore Forming Cytotoxic Proteins) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Immunologic) RN - 0 (Toll-Like Receptors) RN - 0 (fas Receptor) RN - 126465-35-8 (Perforin) RN - 187348-17-0 (Interleukin-12) SB - IM MH - Adaptor Proteins, Signal Transducing MH - Animals MH - Antigens, CD1/analysis MH - Antigens, CD1d MH - Antigens, Differentiation/genetics/*physiology MH - Cytotoxicity Tests, Immunologic MH - *Drosophila Proteins MH - Fas Ligand Protein MH - Female MH - Hepatitis, Animal/etiology/*parasitology/pathology MH - Interleukin-12/genetics/*physiology MH - Interleukin-18/genetics/physiology MH - Killer Cells, Natural/immunology MH - Liver/pathology MH - Malaria/*etiology/pathology MH - Membrane Glycoproteins/genetics/*physiology MH - Mice MH - Mice, Knockout MH - Myeloid Differentiation Factor 88 MH - Perforin MH - *Plasmodium berghei MH - Pore Forming Cytotoxic Proteins MH - Receptors, Cell Surface/*physiology MH - *Receptors, Immunologic MH - T-Lymphocyte Subsets/immunology MH - Toll-Like Receptors MH - fas Receptor/physiology EDAT- 2001/11/08 10:00 MHDA- 2002/01/05 10:01 CRDT- 2001/11/08 10:00 PHST- 2001/11/08 10:00 [pubmed] PHST- 2002/01/05 10:01 [medline] PHST- 2001/11/08 10:00 [entrez] AID - 10.4049/jimmunol.167.10.5928 [doi] PST - ppublish SO - J Immunol. 2001 Nov 15;167(10):5928-34. doi: 10.4049/jimmunol.167.10.5928.